Annovis Bio Inc. is a late-stage clinical drug platform company focused on addressing neurodegeneration in diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). The company is developing buntanetap, a small molecule compound designed to target neurotoxic proteins associated with these conditions.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.